Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. (Q33227656)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

Christian Herzog

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Narain H Punjabi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Emily L Richie

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cyrus H Simanjuntak

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sri Juliani Harjanto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ferry Wangsasaputra

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sumarjati Arjoso

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ainur Rofiq

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mulyati Prijanto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Julitasari

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ursula Yela

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Stanley J Cryz

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

27 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1776-1785

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vaccines for children in rich and poor countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Human immunization in developing countries: practical and theoretical problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Vaccine-preventable disease and immunization in the developing world.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Haemophilus influenzae type b disease and vaccination in Europe: lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Summary statement: The First International Conference on Haemophilus influenzae type b infection in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Toward the development of antibacterial vaccines: report of a symposium and workshop. Organizing Committee

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Commentary: public perception and the safety of immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Haemophilus influenzae type b vaccines: history, choice and comparisons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Acellular pertussis vaccines for infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Impact of anti-vaccine movements on pertussis control: the untold story

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Pertussis vaccine and severe acute neurological illnesses. Response to a recent review by members of the NCES team

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

The efficacy of whole cell pertussis immunisation: collected data on a vaccine produced in France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.023

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.10.023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303216%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33227656&oldid=1967563710"